Testing effectiveness (Phase 2)Study completedNCT04064242
What this trial is testing
Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
Who this might be right for
Pulmonary Sarcoidosis
Novartis Pharmaceuticals 62